Endometriosis latest target for medical cannabis research

Gynica, an Israeli startup specializing in cannabis-based solutions in the field of women’s health, is the first company that will carry out research and development at the newly licensed Lumir Lab established on the campus of the Hebrew University of Jerusalem for the medical cannabis industry.

The lab is headed by analytic chemist Lumír Ondřej Hanuš, one of the world’s leading cannabinoids researchers. Gynica and the Lumir Lab will collaborate on a treatment for endometriosis, a condition where tissue from the uterine lining migrates to other organs inside the body. Approximately 180 million women suffer from endometriosis worldwide.

Gynica is led by Tel Aviv University medical school professor of obstetrics and gynecology Moshe Hod, who also is president of the European Association of Perinatal Medicine.

According to Gynica, the female reproductive system contains the most endocannabinoid receptors in the human body, after the brain.

Studies show that medical cannabis has a

... read more at: https://www.israel21c.org/endometriosis-latest-target-for-medical-cannabis-research/